WEKO3
アイテム
{"_buckets": {"deposit": "3b8458f9-d0af-4029-ac0b-d3603264e90d"}, "_deposit": {"created_by": 11, "id": "3972", "owners": [11], "pid": {"revision_id": 0, "type": "depid", "value": "3972"}, "status": "published"}, "_oai": {"id": "oai:shiga-med.repo.nii.ac.jp:00003972", "sets": ["79", "269", "294"]}, "author_link": ["2890", "8611", "2792", "2909", "675", "6456", "6322", "674", "8612"], "item_4_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-09", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "2974", "bibliographicPageStart": "2969", "bibliographicVolumeNumber": "35", "bibliographic_titles": [{}, {"bibliographic_title": "In vivo (Athens, Greece)", "bibliographic_titleLang": "en"}]}]}, "item_4_creator_3": {"attribute_name": "著者別名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "小出, 博義"}], "nameIdentifiers": [{"nameIdentifier": "8611", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "野田, 哲史"}], "nameIdentifiers": [{"nameIdentifier": "674", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "60865707", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=60865707"}]}, {"creatorNames": [{"creatorName": "吉田, 哲也"}], "nameIdentifiers": [{"nameIdentifier": "6322", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "60510310", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=60510310"}]}, {"creatorNames": [{"creatorName": "影山, 進"}], "nameIdentifiers": [{"nameIdentifier": "2909", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "50378452", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=50378452"}, {"nameIdentifier": "0000-0001-7150-647X", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0001-7150-647X"}]}, {"creatorNames": [{"creatorName": "寺村, 和也"}], "nameIdentifiers": [{"nameIdentifier": "8612", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "0000-0001-9969-7159", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0001-9969-7159"}]}, {"creatorNames": [{"creatorName": "加藤, 威"}], "nameIdentifiers": [{"nameIdentifier": "2792", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "0000-0001-6344-4440", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0001-6344-4440"}]}, {"creatorNames": [{"creatorName": "河内, 明宏"}], "nameIdentifiers": [{"nameIdentifier": "6456", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90240952", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90240952"}]}, {"creatorNames": [{"creatorName": "藤本, 徳毅"}], "nameIdentifiers": [{"nameIdentifier": "2890", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "50378460", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=50378460"}, {"nameIdentifier": "0000-0003-4051-0649", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0003-4051-0649"}]}, {"creatorNames": [{"creatorName": "寺田, 智祐"}], "nameIdentifiers": [{"nameIdentifier": "675", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "10324641", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=10324641"}]}]}, "item_4_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background:\nWe report two cases in which severe skin disorders developed during sorafenib treatment in patients with renal cell carcinoma (RCC) who had previously received nivolumab. ", "subitem_description_type": "Abstract"}, {"subitem_description": "Case report:\nCase 1: A 50-year-old man with RCC received nivolumab as the fifth-line therapy followed by sorafenib as the sixth-line therapy. On day 15 of sorafenib administration, the patient was hospitalized with systemic erythema multiforme, acne-like skin rash, and hand-foot syndrome. Case 2: A 40-year-old man with RCC received nivolumab as the second-line therapy followed by sorafenib as the fifth-line treatment. On day 12 of sorafenib administration, the patient was hospitalized with an acne-like skin rash and hand-foot syndrome. The skin disorders in the two cases improved within 2-3 weeks after sorafenib discontinuation and the start of treatment with topical and oral steroids. ", "subitem_description_type": "Abstract"}, {"subitem_description": "Conclusion:\nWhen using sorafenib in patients previously treated with nivolumab, close attention should be paid to the onset of serious skin disorders. ", "subitem_description_type": "Abstract"}]}, "item_4_description_42": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "Journal Article", "subitem_description_type": "Other"}]}, "item_4_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "International Institute of Anticancer Research"}]}, "item_4_relation_10": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "34410996", "subitem_relation_type_select": "PMID"}}]}, "item_4_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.21873/invivo.12591"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.21873/invivo.12591", "subitem_relation_type_select": "DOI"}}]}, "item_4_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "© 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. "}]}, "item_4_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1791-7549", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "KOIDE, Hiroyoshi"}], "nameIdentifiers": [{"nameIdentifier": "8611", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "NODA, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "674", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "60865707", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=60865707"}]}, {"creatorNames": [{"creatorName": "YOSHIDA, Tetsuya"}], "nameIdentifiers": [{"nameIdentifier": "6322", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "60510310", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=60510310"}]}, {"creatorNames": [{"creatorName": "KAGEYAMA, Susumu"}], "nameIdentifiers": [{"nameIdentifier": "2909", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "50378452", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=50378452"}, {"nameIdentifier": "0000-0001-7150-647X", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0001-7150-647X"}]}, {"creatorNames": [{"creatorName": "TERAMURA, Kazuya"}], "nameIdentifiers": [{"nameIdentifier": "8612", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "0000-0001-9969-7159", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0001-9969-7159"}]}, {"creatorNames": [{"creatorName": "KATO, Takeshi"}], "nameIdentifiers": [{"nameIdentifier": "2792", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "0000-0001-6344-4440", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0001-6344-4440"}]}, {"creatorNames": [{"creatorName": "KAWAUCHI, Akihiro"}], "nameIdentifiers": [{"nameIdentifier": "6456", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "90240952", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=90240952"}]}, {"creatorNames": [{"creatorName": "FUJIMOTO, Noriki"}], "nameIdentifiers": [{"nameIdentifier": "2890", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "50378460", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=50378460"}, {"nameIdentifier": "0000-0003-4051-0649", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0003-4051-0649"}]}, {"creatorNames": [{"creatorName": "TERADA, Tomohiro"}], "nameIdentifiers": [{"nameIdentifier": "675", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "10324641", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=10324641"}]}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Sorafenib", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "immunotherapy", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "nivolumab", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "renal cell carcinoma", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "skin disorder", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients."}]}, "item_type_id": "4", "owner": "11", "path": ["79", "269", "294"], "permalink_uri": "http://hdl.handle.net/10422/00013070", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-09-15"}, "publish_date": "2021-09-15", "publish_status": "0", "recid": "3972", "relation": {}, "relation_version_is_last": true, "title": ["Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients."], "weko_shared_id": -1}
Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients.
http://hdl.handle.net/10422/00013070
http://hdl.handle.net/10422/000130700754f323-d45c-4a92-8284-544158a7da9b
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-09-15 | |||||
タイトル | ||||||
タイトル | Severe Skin Disorders Due to Sorafenib Use After Nivolumab Treatment in Renal Cell Carcinoma Patients. | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Sorafenib | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | immunotherapy | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | nivolumab | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | renal cell carcinoma | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | skin disorder | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
KOIDE, Hiroyoshi
× KOIDE, Hiroyoshi× NODA, Satoshi× YOSHIDA, Tetsuya× KAGEYAMA, Susumu× TERAMURA, Kazuya× KATO, Takeshi× KAWAUCHI, Akihiro× FUJIMOTO, Noriki× TERADA, Tomohiro |
|||||
著者別名 |
小出, 博義
× 小出, 博義× 野田, 哲史× 吉田, 哲也× 影山, 進× 寺村, 和也× 加藤, 威× 河内, 明宏× 藤本, 徳毅× 寺田, 智祐 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: We report two cases in which severe skin disorders developed during sorafenib treatment in patients with renal cell carcinoma (RCC) who had previously received nivolumab. |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Case report: Case 1: A 50-year-old man with RCC received nivolumab as the fifth-line therapy followed by sorafenib as the sixth-line therapy. On day 15 of sorafenib administration, the patient was hospitalized with systemic erythema multiforme, acne-like skin rash, and hand-foot syndrome. Case 2: A 40-year-old man with RCC received nivolumab as the second-line therapy followed by sorafenib as the fifth-line treatment. On day 12 of sorafenib administration, the patient was hospitalized with an acne-like skin rash and hand-foot syndrome. The skin disorders in the two cases improved within 2-3 weeks after sorafenib discontinuation and the start of treatment with topical and oral steroids. |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Conclusion: When using sorafenib in patients previously treated with nivolumab, close attention should be paid to the onset of serious skin disorders. |
|||||
書誌情報 |
en : In vivo (Athens, Greece) 巻 35, 号 5, p. 2969-2974, 発行日 2021-09 |
|||||
出版者 | ||||||
出版者 | International Institute of Anticancer Research | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1791-7549 | |||||
PMID | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 34410996 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.21873/invivo.12591 | |||||
関連名称 | 10.21873/invivo.12591 | |||||
権利 | ||||||
権利情報 | © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Journal Article |